Now hiring

Find the Houston tech job you want with the help of Station Houston

Station Houston is hosting a tech job fair on Tuesday, February 19. Station Houston/Facebook

Houston is a great place to grow, thanks to the low cost of living, booming job market and strong economy. In fact, a recent study predicted that Houston will end the year with 3.2 million payroll jobs – a net increase of more than 600,000 jobs over the past decade. In Houston (which recently nearly matched Austin in VC funding), the dollar goes much further than other tech-centric markets like Silicon Valley, making it more attractive for startups and technology companies to grow here too.

With new employers Amazon Web Services and Bill.com, among others, Houston's innovation scene is thriving and needs to fill jobs. That's where Station Houston, Houston's hub for tech startups, entrepreneurs and innovation, comes in with its hiring event, Startup Gigs, on Tuesday, February 19.

Details
At Startup Gigs, Station will bring engineering, product, sales, marketing, and design professionals together with Houston's community of growing startups. The goal of the event is to reach untapped talent and industry experts interested in joining a startup and or tech team. Did we mention it's free to attend?

Date: Tuesday, February 19, 2019
Time: 5:30 to 7 pm
Register here.

Who's Hiring?

Startups:

Trending News

Building Houston

 
 

You can now hop online and invest in this promising cell therapy startup. Photo via Getty Images

A clinical-stage company headquartered in Houston has opened an online funding campaign.

FibroBiologics, which is developing fibroblast cell-based therapeutics for chronic diseases, launched a campaign with equity crowdfunding platform StartEngine. The platform lets anyone — regardless of their net worth or income level — to invest in securities issued by startups.

The funding, according to a press release, will be used to support ongoing operations of Fibrobiologics and advance its clinical programs in multiple sclerosis, degenerative disc disease, wound care, extension of life, and cancer.

"We're excited to partner with StartEngine on this campaign. StartEngine has over 600,000 investors as part of their community and has raised over half a billion dollars for its clients," says FibroBiologics' Founder and CEO Pete O'Heeron, in the release.

"This is an exciting time at FibroBiologics as we continue progressing our clinical pipeline and developing innovative therapies to treat chronic diseases," he continues. "This new funding will fuel our growth in the lab and bring us one step closer to commercialization."

The campaign, launched this week, already has over 100 investors, at the time of publication, and has raised nearly $2 million, according to the page. The minimum investment is set at around $500, and the company's indicated valuation is $252.57 million.

In 2021, FibroBiologics announced its intention of going public. Last year, O'Heeron told InnovationMap on the Houston Innovators Podcast of the company's growth plans as well as the specifics of the technology.

Only two types of cells — stem cells and fibroblasts — can be used in cell therapy for a regenerative treatment, which is when specialists take healthy cells from a patient and inject them into a part of the body that needs it the most. As O'Heeron explains in the podcast, fibroblasts can do it more effectively and cheaper than stem cells.

"(Fibroblasts) can essentially do everything a stem cell can do, only they can do it better," says O'Heeron. "We've done tests in the lab and we've seen them outperform stem cells by a low of 50 percent to a high of about 220 percent on different disease paths."


Trending News